pocketful logo light
pocketful logo light
Hester Biosciences Ltd logo

Hester Biosciences Ltd

NSE: HESTERBIO BSE: 524669

₹1942.40

(1.06%)

Wed, 17 Jun 2026, 02:51 am

mtf coin illustrationMTF 5x

Hester Biosciences Share Price Live Chart

1 Day

(1.06%)

No Result Found

Summary

  • Market Cap (in Cr)

    1702.18

  • Net Profit (in Cr)

    28.83

  • P/B

    3.39

  • Sector P/E

    33.76

  • P/E

    38.81

  • EV/EBITDA

    18.42

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    9.51

  • ROCE

    8.86

  • Debt/Equity

    0.76

  • EPS (TTM)

    62.79

  • Dividend Yield

    0.55

  • Book Value

    423.47

  • Interest Cover

    4.12

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters53.7353.7353.7353.7353.73
FII0.380.510.530.040.87
DII0.000.010.000.020.02
Public45.8945.7545.7446.2045.38
Government00000

Read More

Technical Analysis

RSI

65.62

MACD

77.49

50 DMA

1729.20

200 DMA

1675.93

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic3204.032578.932294.071953.831668.971328.73703.63
Fibonacci2578.932340.152192.621953.831715.051567.521328.73
Camarilla2181.102123.802066.501953.831951.901894.601837.30

Pivots Level: Classic

R3

+1250.20

3204.03

R2

+625.10

2578.93

R1

+340.23

2294.07

1953.83
1953.83
Pivot Point
LTP: 2054.40

S1

-284.87

1668.97

S2

-625.10

1328.73

S3

-1250.20

703.63

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1986.61

  • 20-EMA

    1934.41

  • 30-EMA

    1877.86

  • 50-EMA

    1790.32

  • 100-EMA

    1699.70

  • 200-EMA

    1698.33

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 May 2026board-meetingsAccounts, Final Dividend
30 Jan 2026board-meetingsQuarterly Results
11 Jul 2025agm
06 Jul 2025dividendFinal Dividend - Rs. - 706 Aug 2025
09 May 2025dividend₹7.00 Dividend /Share06 Aug 2025
26 Jul 2024agm
22 Jul 2024agmAnnual General Meeting23 Aug 2024
22 Jul 2024dividendDividend - Rs 6 Per Share22 Aug 2024
10 May 2024dividend₹6.00 Dividend /Share23 Aug 2024
23 Aug 2023agm

Read More

Peer Comparison

Hester Biosciences Ltd logo

Hester Biosciences Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Hester Biosciences Ltd About

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1987

Headquarters

CEO

Bhupendra V Gandhi

Employees

Contact

Website icon

Website

http://www.hester.in

Email icon

Email

investor@hesterbiosciences.co.in

Phone icon

Phone

91-079-26445107

Location icon

Location

1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006

Read More

Hester Biosciences Ltd Company History

YearHistory
2013
  • Hester Biosciences received WHO GMP Certification.
  • Hester launched Bivalent Marek's Disease Live Vaccine.
2014
  • Hester Biosciences board approved a scheme of amalgamation.
  • The Company recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each for the financial year 2013-14.
2015
  • Hester Biosciences launched PPR vaccine and Goat Pox vaccine.
2020
  • Hester Nepal launched the thermo-tolerant PPR Vaccine.
2021
  • Hester to produce and commercialize Classical Swine Fever Vaccine and Sheep Pox Vaccine.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
HESTER COblockSell90000732.122 Mar 2017
RAJIV DINblockBuy90000732.122 Mar 2017
HESTER COATINGS PRIVATE LIMITEDbulkSell90000732.122 Mar 2017
RAJIV DINESH GANDHIbulkBuy90000732.122 Mar 2017
K PAL JOYbulkSell4780027621 Aug 2014
SHIRIN DHUNJISHAW GHANDHIbulkSell60000171.801 Jul 2014
PIYUSH BATUKBHAI DAVEbulkBuy50000110.2324 Jun 2013
PIYUSH BATUKBHAI DAVEbulkSell50000110.6724 Jun 2013
VIRAJBEN SIDDHARTHBHAI PATELbulkBuy2850512622 Aug 2012
JASHWANT JAGMOHAN SHAHbulkSell2850512622 Aug 2012

Read More

Hester Biosciences Ltd News

Hester Biosciences FY26 PAT Surges 99%; INR 11 Dividend Recommended

Hester Biosciences reported consolidated FY26 PAT of INR 574.84 million (+99% YoY) and standalone PAT of INR 521.00 million (+64% YoY), with INR 11 per share dividend recommended.

19 May 2026

companies

Hester Biosciences Q4 PAT surges 174% on strong execution

Hester Biosciences Q4 standalone PAT rose 174% to INR 263.84 mn, revenue up 22%. Consolidated Q4 PAT surged 974%. Board recommends INR 11/share dividend for FY26.

19 May 2026

companies

Hester Biosciences FY26 PAT Surges 99%; INR 11 Dividend Recommended

Hester Biosciences reported consolidated FY26 PAT of INR 574.84 million (+99% YoY) and standalone PAT of INR 521.00 million (+64% YoY), with INR 11 per share dividend recommended.

19 May 2026

companies

Hester Biosciences FY26 PAT Surges 64%; Files Results in Financial Express

Hester Biosciences reported FY26 standalone PAT of INR 521.00 million (+64% YoY) and consolidated PAT of INR 574.84 million (+99% YoY), with results published in Financial Express on May 16, 2026.

18 May 2026

companies

Hester Biosciences Q4 PAT surges 174% on strong execution

Hester Biosciences Q4 standalone PAT rose 174%, revenue up 22%. Poultry Healthcare grew 41% in Q4. Net debt reduced to ₹70 crores; debt-to-equity at 0.19x.

18 May 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number